MARKET

ECOR

ECOR

Electrocore
NASDAQ
8.96
+0.87
+10.75%
After Hours: 9.00 +0.04 +0.45% 19:49 08/10 EDT
OPEN
8.02
PREV CLOSE
8.09
HIGH
8.99
LOW
7.68
VOLUME
51.68K
TURNOVER
--
52 WEEK HIGH
10.50
52 WEEK LOW
4.160
MARKET CAP
80.78M
P/E (TTM)
-5.0476
1D
5D
1M
3M
1Y
5Y
1D
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)
TipRanks · 14h ago
Weekly Report: what happened at ECOR last week (0803-0807)?
Weekly Report · 18h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)
TipRanks · 3d ago
electroCore raises FY26 revenue view to up over 30% from up 30%
TipRanks · 4d ago
Press Release: electroCore Announces Second -3-
Dow Jones · 4d ago
*electroCore 2Q Sales $9.45M >ECOR
Dow Jones · 4d ago
Here are the major earnings after the close Thursday
Seeking Alpha · 4d ago
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates
NASDAQ · 6d ago
More
About ECOR
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

Webull offers electroCore, Inc. stock information, including NASDAQ: ECOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ECOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ECOR stock methods without spending real money on the virtual paper trading platform.